Detroit, Miami, Phoenix and New York are among the markets with the most room for so-called "payvider" partnerships to grow, a new report finds. The consultancy Guidehouse studied more than 100 U.S. markets' populations, insurance enrollment and cost and quality metrics to compile its report, which…
Credit: Procyrion, Inc.
DETROIT (June 3, 2021) - Cardiologists at Henry Ford Hospital are first in the U.S. and second in the world to implant a circulatory support device that is being investigated in a clinical trial for patients hospitalized with acute decompensated heart failure (ADHF) and worsening kidney function, a condition known as cardiorenal syndrome.
The Aortix™ System from Procyrion, Inc. is an intra-aortic axial flow pump, which is deployed via a femoral catheter to the descending aorta. This tiny pump, thinner than the size of a #2 pencil, is designed to relieve some of the heart s workload, allowing the heart to recover while more effectively pushing blood flow to the kidneys.